(Q33369562)

26 July 2017

1 reference

title

Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? (English)

1 reference

26 July 2017

1 reference

Stanworth SJ

1

1 reference

26 July 2017

Hyde C

series ordinal

2

1 reference

26 July 2017

Brunskill S

series ordinal

3

1 reference

26 July 2017

Murphy MF

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

British Journal of Haematology

26 July 2017

1 reference

26 July 2017

131

1 reference

26 July 2017

5

1 reference

26 July 2017

588-595

1 reference

What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?

26 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Guidelines for the use of platelet transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Methods for the analysis of bleeding outcomes in randomized trials of PLT transfusion triggers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

THE RELATION OF BLOOD PLATELETS TO HEMORRHAGIC DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Compliance with prophylactic platelet transfusion trigger in haematological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

An interlaboratory study of a candidate reference method for platelet counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Platelet counting by the RBC/platelet ratio method. A reference method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Risks associated with transfusion of cellular blood components in canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Measurement of bleeding severity: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Appropriateness and safety of blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Controversies in platelet transfusion therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Relationship between platelet count and bleeding risk in thrombocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Prophylactic platelet transfusions: which dose is the best dose? A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

New strategies for prophylactic platelet transfusion in patients with hematologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

The effectiveness of interventions to reduce physician's levels of inappropriate transfusion: what can be learned from a systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05769.X

10.1111/J.1365-2141.2005.05769.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference